Physician profile
Arvinder Chani
NPI 1487655775
$4,678.74
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $973 · 2021: $1,557 · 2022: $768 · 2023: $185 · 2024: $23.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $907.42 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $706.32 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $457.21 | 2019-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $440.08 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $325.23 | 2020-2022 | |
| Abbvie INC. | $262.11 | 2021-2022 | |
| Allergan, INC. | $251.66 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $173.94 | 2019-2023 | |
| Lundbeck LLC | $160.08 | 2019-2020 | |
| Harmony Biosciences LLC | $151.88 | 2021-2023 | Wakix |
| Bausch Health US, LLC | $145.79 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $129.46 | 2019-2022 | |
| Alkermes, INC. | $126.35 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $113.02 | 2020-2022 | |
| Inspire Medical Systems, INC. | $99.20 | 2023 | Inspire |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $47.98 | 2022-2024 | Perseris |
| Takeda Pharmaceuticals U.S.A., INC. | $39.46 | 2019-2021 | |
| Axsome Therapeutics, INC. | $37.49 | 2023 | Sunosi, Auvelity |
| Eisai INC. | $36.29 | 2021 | |
| Sage Therapeutics, LLC | $31.73 | 2021 | |
| Neuronetics, INC. | $24.48 | 2019-2020 | |
| Noven Therapeutics, LLC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvinder Chani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.